Follow
Morteza Akbari
Morteza Akbari
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
Innate and adaptive immune responses against coronavirus
A Hosseini, V Hashemi, N Shomali, F Asghari, T Gharibi, M Akbari, ...
Biomedicine & pharmacotherapy 132, 110859, 2020
1552020
Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment
Z Jahanafrooz, J Mosafer, M Akbari, M Hashemzaei, A Mokhtarzadeh, ...
Journal of cellular physiology 235 (5), 4153-4166, 2020
1242020
CD133: An emerging prognostic factor and therapeutic target in colorectal cancer
M Akbari, N Shomali, A Faraji, D Shanehbandi, M Asadi, A Mokhtarzadeh, ...
Cell biology international 44 (2), 368-380, 2020
462020
miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4
MRMH Azar, H Aghazadeh, HN Mohammed, MRS Sara, A Hosseini, ...
International immunopharmacology 92, 107355, 2021
432021
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; combination of oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
A Mardi, AV Shirokova, RN Mohammed, A Keshavarz, AO Zekiy, ...
Cancer Cell International 22 (1), 168, 2022
402022
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
H Yari, MV Mikhailova, M Mardasi, M Jafarzadehgharehziaaddin, ...
Stem cell research & therapy 13 (1), 423, 2022
372022
miR‐143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro
SA Nabipoorashrafi, N Shomali, L Sadat‐Hatamnezhad, ...
IUBMB life 72 (9), 2034-2044, 2020
372020
Dysregulated microRNAs in colorectal carcinogenesis: new insight to cell survival and apoptosis regulation
A Anvarnia, F Mohaddes‐Gharamaleki, M Asadi, M Akbari, B Yousefi, ...
Journal of cellular physiology 234 (12), 21683-21693, 2019
362019
Harmful effects of high amounts of glucose on the immune system: An updated review
N Shomali, J Mahmoudi, A Mahmoodpoor, RE Zamiri, M Akbari, H Xu, ...
Biotechnology and Applied Biochemistry 68 (2), 404-410, 2021
332021
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
RN Mohammed, R Tamjidifar, HS Rahman, A Adili, S Ghoreishizadeh, ...
Cell Communication and Signaling 20 (1), 79, 2022
312022
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
F Marofi, HS Rahman, L Thangavelu, A Dorofeev, F Bayas-Morejón, ...
Stem cell research & therapy 12, 1-21, 2021
312021
The Improvement of Production Profile While Managing Reservoir Uncertainties with Inflow Control Devices Completions
M MoradiDowlatabad, F Zarei, M Akbari
SPE Norway Subsurface Conference?, SPE-173841-MS, 2015
302015
Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations
R Tamjidifar, M Akbari, S Tarzi, M Sadeghzadeh, M Abolghasemi, ...
Journal of gastrointestinal cancer 52, 125-129, 2021
202021
Considerations for optimum inflow control devices (ICDs) selection and placement in horizontal sections
M Akbari, JR Gonzalez, N Macklin
SPE Russian Petroleum Technology Conference?, SPE-171281-MS, 2014
172014
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
M Sajjadi-Dokht, TAM Mohamad, HS Rahman, MS Maashi, S Danshina, ...
Genes & diseases 9 (4), 849-867, 2022
162022
Introducing a novel beta-ray sensor based on polycarbonate/bismuth oxide nanocomposite
SM Safdari, S Malekie, S Kashian, M Akbari
Scientific Reports 12 (1), 2496, 2022
162022
An investigation for an optimized neutron energy-group structure in thermal lattices using Particle Swarm Optimization
M Akbari, A Minuchehr, A Zolfaghari, F Khoshahval
Annals of Nuclear Energy 47, 53-61, 2012
152012
Synthesis and anticancer activity of 2, 4, 5-triaryl imidazole derivatives
F Elahian, M Akbari, M Ghasemi, N Behtooee, M Taheri, M Amini
Letters in Drug Design & Discovery 11 (7), 840-843, 2014
132014
Major depressive disorder: Biomarkers and biosensors
M Dadkhah, M Jafarzadehgharehziaaddin, S Molaei, M Akbari, F Fathi
Clinica Chimica Acta, 117437, 2023
122023
Dysregulation of miR-27a and SMAD2 can be a reliable indicator in the prognosis and diagnosis of CRC as well as in response to chemotherapy drugs
MRMH Azar, M Akbari, HN Mohammed, M Asadi, D Shanehbandi, ...
Gene Reports 21, 100844, 2020
122020
The system can't perform the operation now. Try again later.
Articles 1–20